Apellis Inventory from 2010 to 2026

APLS Stock  USD 21.42  0.71  3.21%   
Apellis Pharmaceuticals Inventory yearly trend continues to be comparatively stable with very little volatility. Inventory is likely to outpace its year average in 2026. From the period from 2010 to 2026, Apellis Pharmaceuticals Inventory quarterly data regression had r-value of  0.81 and coefficient of variation of  158.14. View All Fundamentals
 
Inventory  
First Reported
2014-12-31
Previous Quarter
122.8 M
Current Value
142.6 M
Quarterly Volatility
58 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Apellis Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apellis Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 46.5 M or Selling General Administrative of 504.4 M, as well as many indicators such as Price To Sales Ratio of 5.53, Dividend Yield of 0.0 or PTB Ratio of 16.25. Apellis financial statements analysis is a perfect complement when working with Apellis Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Apellis Stock
Check out the analysis of Apellis Pharmaceuticals Correlation against competitors.
For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.
The evolution of Inventory for Apellis Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Apellis Pharmaceuticals compares to historical norms and industry peers.

Latest Apellis Pharmaceuticals' Inventory Growth Pattern

Below is the plot of the Inventory of Apellis Pharmaceuticals over the last few years. It is Apellis Pharmaceuticals' Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apellis Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Slightly volatile
   Inventory   
       Timeline  

Apellis Inventory Regression Statistics

Arithmetic Mean37,194,772
Geometric Mean25,816
Coefficient Of Variation158.14
Mean Deviation49,508,934
Median342,743
Standard Deviation58,820,571
Sample Variance3459.9T
Range149.7M
R-Value0.81
Mean Square Error1296.8T
R-Squared0.65
Significance0.000096
Slope9,381,080
Total Sum of Squares55357.8T

Apellis Inventory History

2026149.7 M
2025142.6 M
202482.5 M
2023146.4 M
202285.7 M
202124 M

Other Fundumenentals of Apellis Pharmaceuticals

Apellis Pharmaceuticals Inventory component correlations

About Apellis Pharmaceuticals Financial Statements

Apellis Pharmaceuticals shareholders use historical fundamental indicators, such as Inventory, to determine how well the company is positioned to perform in the future. Although Apellis Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Apellis Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Apellis Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Inventory142.6 M149.7 M
Change To Inventory-9.7 M-10.2 M
Inventory Turnover 0.72  0.46 
Days Of Inventory On Hand 508.95  483.50 
Average Inventory216 K192 K
Days Of Inventory Outstanding 508.95  483.50 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Apellis Stock Analysis

When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.